India's expert panel recommends Covaxin trials on 2-18 year-olds

As per the official sources, the trial for the vaccine will take place in 525 subjects at different sites, including AIIMS, Patna, AIIMS, Delhi, and Meditrina Institute of Medical Sciences, Nagpur.

Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old

Bharat Biotech reduces price of Covaxin for Indian state governments

Indian Govt asks Serum Institute, Bharat Biotech to lower price of COVID-19 vaccines: Official sources  

Bharat Biotech prices Covaxin at Rs 600 for states, Rs 1,200 for pvt hospitals  

The Indian vaccine manufacturer Bharat Biotech has released its amended prices as the country aims to open up vaccination drive to all adults from 1 May.

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination

Covaxin has an efficacy of 78% against severe Covid-19 cases: Bharat BioTech

Bharat Biotech has announced the Phase 3 clinical trial results for its Coronavirus vaccine candidate Covaxin. The company said that Covaxin demonstrated an efficacy of 81 per cent in the trials.

Bharat Biotech announces successful Phase-3 trial results of Covaxin

Participants received a vaccine or placebo in a 1:1 ratio, which showed that the vaccine candidate was well tolerated, said the company

Covaxin showed 81% efficacy against UK variant

Bharat Biotech's Covaxin found 81% efficient in Phase 3 trials

According to reports, Chinese hacking groups are targeting Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech. Both SII and Bharat Biotech are involved in producing the COVID-19 vaccine.

Report: Hackers target Indian vaccine makers SII, Bharat Biotech

Brazil signs deal with India's Bharat Biotech for 20 million Covid-19 vaccine doses

India has exported vaccines worth Rs 338 crore: Government declares in Parliament

According to a new study, India's homegrown jab Covaxin is likely to be effective against the UK variant of the Coronavirus. Covaxin is developed by Bharat Biotech, it has been approved for emergency use by India's drug regulators.

Study: Covaxin developed by Indian Pharma firm Bharat Biotech neutralizes UK variant

GSK to move malaria vaccine production to India's Bharat Biotech

Bharat Biotech's COVID-19 shot safe, produced immune response in early human trial: Study

India's Bharat Biotech seeks emergency use approval for vaccine in Philippines

Gap of 28 days between two Covid vaccine doses, effectiveness to begin after 14 days: Government

Coronavirus vaccine arrives in Hyderabad; Gujarat, Tamil Nadu set to receive consignment

Bill Gates and other world leaders applaud India for quick vaccine production

Expert panel recommends India's indigenously developed Covid-19 vaccine Covaxin for restricted emergency use

Brazil's private clinics seek India's COVAXIN vaccine

Indian Government to approve their vaccine called COVAXIN by Bharat Biotech, this could be a game changer in fight against covid pandemic. The vaccine is currently on Phase 3rd trial.

Indian vaccine could be the game changer in fight against COVID-19

Covishield, Covaxin are safe and provide robust immune response, says Drug Controller General of India VG Somani

bharat-biotech

Bharat Biotech, News on Bharat Biotech, stories on Bharat Biotech, articles on Bharat Biotech, Bharat Biotech stories at Wion, Bharat Biotech news, Bharat Biotech latest news

bharat biotech